MET · Metlife Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.07B | - | $17.36B | $17.34B | $18.57B | - | $18.44B | $17.82B | $16.06B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $132.00M | - | $118.00M | $130.00M | $126.00M | - | $162.00M | $153.00M | $148.00M | - |
| Total Operating Expenses | $3.80B | - | $3.51B | $3.32B | $3.35B | - | $3.26B | $3.18B | $3.22B | - |
| D&A | $29.00M | - | $30.00M | $28.00M | $29.00M | - | $32.00M | $30.00M | $29.00M | - |
| Operating Income | $1.63B | - | $1.44B | $1.39B | $1.40B | - | $1.99B | $1.20B | $1.04B | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $345.00M | - | $308.00M | $245.00M | $404.00M | - | $653.00M | $249.00M | $170.00M | - |
| Net Income | $1.19B | - | $896.00M | $729.00M | $945.00M | - | $1.34B | $946.00M | $867.00M | - |
| EPS - Basic | $1.75 | - | $1.23 | $1.04 | $1.29 | - | $1.82 | $1.28 | $1.11 | - |
| EPS - Diluted | $1.74 | - | $1.22 | $1.03 | $1.28 | - | $1.81 | $1.28 | $1.10 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22.69B | $22.03B | $20.23B | $22.18B | $21.33B | $20.07B | $21.77B | $20.79B | $19.84B | $20.64B |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $743.21B | $745.17B | $719.73B | $702.47B | $688.32B | $677.46B | $704.98B | $675.75B | $677.58B | $687.58B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $715.41B | $716.25B | $690.53B | $674.54B | $660.56B | $649.75B | $673.81B | $648.21B | $648.78B | $657.33B |
| Stockholders' Equity | $27.32B | $28.40B | $28.94B | $27.68B | $27.49B | $27.45B | $30.89B | $27.25B | $28.54B | $30.02B |
| Retained Earnings | $45.06B | $44.29B | $43.89B | $43.45B | $43.13B | $42.63B | $41.77B | $40.87B | $40.35B | $40.15B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.69B | - | - | - | $4.26B | - | - | - | $2.33B | - |
| Investing Cash Flow | ($5.46B) | - | - | - | ($3.32B) | - | - | - | ($2.63B) | - |
| Financing Cash Flow | $3.56B | - | - | - | $220.00M | - | - | - | ($261.00M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 8.6% | - | 8.3% | 8.0% | 7.5% | - | 10.8% | 6.7% | 6.5% | - |
| EBITDA margin | 8.7% | - | 8.5% | 8.2% | 7.7% | - | 11.0% | 6.9% | 6.7% | - |
| Net margin | 6.2% | - | 5.2% | 4.2% | 5.1% | - | 7.3% | 5.3% | 5.4% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 0.7% | - | 0.7% | 0.7% | 0.7% | - | 0.9% | 0.9% | 0.9% | - |
| Effective tax rate | 22.5% | - | 25.6% | 25.2% | 29.9% | - | 32.7% | 20.8% | 16.4% | - |
| Return on assets | 0.2% | - | 0.1% | 0.1% | 0.1% | - | 0.2% | 0.1% | 0.1% | - |
| Return on equity | 4.3% | - | 3.1% | 2.6% | 3.4% | - | 4.3% | 3.5% | 3.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 27.20 | 26.24 | 24.87 | 25.37 | 25.04 | 24.68 | 22.83 | 24.80 | 23.75 | 22.91 |
| Liabilities / Assets | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| Efficiency | ||||||||||
| Asset turnover | 0.03 | - | 0.02 | 0.02 | 0.03 | - | 0.03 | 0.03 | 0.02 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 40.6x | - | 67.5x | 78.1x | 62.7x | - | 45.6x | 54.8x | 67.4x | - |
| P / B | 1.7x | - | 1.9x | 2.0x | 2.0x | - | 1.9x | 1.8x | 1.9x | - |
| P / S | 2.4x | - | 3.2x | 3.1x | 3.0x | - | 3.1x | 2.8x | 3.4x | - |
| EV / EBITDA | 14.3x | - | 23.7x | 22.6x | 23.7x | - | 17.9x | 23.8x | 31.8x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 2.7% | - | -5.9% | -2.7% | 15.6% | - | 16.2% | 7.2% | 4.3% | - |
| Revenue CAGR (3y) | 7.4% | - | -8.0% | 3.7% | 5.6% | - | 2.9% | -1.3% | 1.0% | - |
| Revenue CAGR (5y) | 4.2% | - | 1.6% | 4.2% | 0.3% | - | -0.3% | 0.4% | -0.3% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 16.4% | - | -27.7% | 15.9% | 34.1% | - | 273.4% | 179.5% | 306.6% | - |
| Net income growth (YoY) | 25.4% | - | -33.2% | -22.9% | 9.0% | - | 174.4% | 135.3% | 983.8% | - |
| EPS growth (YoY) | 35.9% | - | -32.6% | -19.5% | 16.4% | - | 223.2% | 166.7% | 5400.0% | - |
| EPS CAGR (3y) | 343.1% | - | 43.8% | 99.4% | 20.6% | - | 0.7% | -30.6% | 49.4% | - |
| EPS CAGR (5y) | 39.4% | - | 12.1% | 71.2% | -23.1% | - | -4.7% | -6.3% | -4.7% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.6% | 3.5% | -6.3% | 1.6% | -3.7% | -8.6% | 20.4% | -9.9% | -11.4% | 11.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$72.27B totalGroup Benefits Segment$26.88B · 37.2%
Retirement And Income Solutions Segment$21.04B · 29.1%
Asia Segment$11.96B · 16.5%
Latin America Segment$8.30B · 11.5%
EMEASegment$3.15B · 4.4%
Met Life Investment Management Segment$938.00M · 1.3%
Product / service
$2.44B totalPrepaidlegalplansandadministrativeonlycontracts$637.00M · 26.1%
Vision Fee For Service Arrangements$561.00M · 23.0%
Otherrevenuefromservicecontractsfromcustomers$432.00M · 17.7%
Feebasedinvestmentmanagementservices$369.00M · 15.1%
Administrative Service$295.00M · 12.1%
Distribution Service$142.00M · 5.8%
Peer comparison
Same SIC group: Life Insurance
Comparing METLIFE INC against the 5 most active filers in the same SIC group.
Dividends
$2.30/share trailing 12 months · +4.3% YoY
| Ex-date | Per share |
|---|---|
| May 12, 2026 | $0.5930 |
| Feb 3, 2026 | $0.5680 |
| Nov 4, 2025 | $0.5680 |
| Aug 5, 2025 | $0.5680 |
| May 6, 2025 | $0.5680 |
| Feb 4, 2025 | $0.5450 |
| Nov 5, 2024 | $0.5450 |
| Aug 6, 2024 | $0.5450 |
| May 6, 2024 | $0.5450 |
| Feb 5, 2024 | $0.5200 |
| Nov 8, 2023 | $0.5200 |
| Aug 7, 2023 | $0.5200 |
| May 8, 2023 | $0.5200 |
| Feb 6, 2023 | $0.5000 |
| Nov 7, 2022 | $0.5000 |
| Aug 8, 2022 | $0.5000 |
| May 9, 2022 | $0.5000 |
| Feb 7, 2022 | $0.4800 |
| Nov 8, 2021 | $0.4800 |
| Aug 9, 2021 | $0.4800 |
| May 10, 2021 | $0.4800 |
| Feb 4, 2021 | $0.4600 |
| Nov 2, 2020 | $0.4600 |
| Aug 3, 2020 | $0.4600 |